The BSAVA has launched a new app for iPhone / Android users, the Guide to Procedures in Small Animal Practice.
The guide, which is aimed at vets and students, covers more than 70 of the diagnostic and therapeutic procedures commonly performed in small animal veterinary practice.
The Association says it always planned to extend the number of digital member benefits, but has been spurred on by feedback about its Formulary app, like this comment from 'talland' on the iTunes store: "Absolutely fantastic App - in some ways even easier to use than the book itself. Well done BSAVA. It'd be great if the Guide to Procedures in Small Animal Practice could be an App too".
The BSAVA says the key features of the new app are:
Once installed on your phone you will need to launch the Application by entering a unique activation code which can be obtained from the App Activation Code page (member login required).
The British Veterinary Association has criticised the conclusions drawn by the Gloucestershire Wildlife Trust in its report on badger vaccine deployment.
The report considers the effectiveness of the Trust's programme of deploying the injectable BadgerBCG vaccine in seven nature reserves covering only 170 hectares (1.7 sq km) during the summer.
It concludes that the badger vaccine is a viable alternative to culling in the battle against bovine TB, but according to the BVA, does not give evidence to support this claim.
Carl Padgett, President of the BVA, said: "We welcome the initiative by the Gloucestershire Wildlife Trust to investigate the deployment of the badger vaccine but this work must not be confused with an investigation into the effectiveness of the badger vaccine in reducing or eradicating bovine TB.
"To conclude from this report that the badger vaccine is a viable alternative to culling in eradicating TB is unrealistic at best and spin at worst.
"The fact remains that the vaccine has no protective effect on infected badgers and we know that at least 30-40% of badgers within an area will be infected. Many young badgers will be infected before they can be trapped and injected.
"In terms of the practicalities of deployment this report provides interesting information but we will learn much more as a result of Defra's Badger Vaccine Deployment Project which is looking at a much larger area of 100 sq km.
"Vaccination of badgers certainly has a role to play in an effective TB eradication programme but it is only one tool in the toolbox."
Hill's has launched 'Lose 60 Tonnes in 6 months', a campaign to help clients get their pet to a healthy weight.
Sixty tonnes is equivalent to the weight of twelve elephants, which is a huge target. Hill's says that if every practice makes a small contribution, it can be achieved.
Hill's support includes a public relations pack which the company says contains everything veterinary surgeons and nurses need to help raise awareness and encourage pet owners to bring their pets in for a weight assessment. The pack includes proforma press releases and guidance on how to cultivate a mutually beneficial relationship with local media. There is also a 'Lose 60 tonnes in 6 months' point of sale kit that includes a poster, stickers and a noticeboard kit for clinics, to drive awareness while clients wait for consults.
As part of the campaign, Hill's is also hosting a series of nurse webinars on weight management and offering additional support material such as consult room posters, weight clinic packs and pet tape measures, an item often requested by nurses. There are also promotional offers available through Hill's Territory Managers, subject to stock availability.
Hill's Customer Marketing Manager, Sara Locke MRCVS said: "We feel it is important to support practices at the grass-roots level and to develop a campaign that will have real meaning within the local community. I hope practices will get behind it, engage with pet owners and as a result, gain new clients. They are also helping thousands of pets live longer and happier lives."
Further information is available from local Hill's Territory Managers or by calling Hill's on 0800 242438 or in ROI 1 800 626002.
A research project funded by equine charity The Horse Trust has found that lameness is the most common reason for euthanasing a geriatric horse.
According to the charity, this research is the first in the UK to provide data on the causes of death in geriatric horses. Although post-mortem studies have provided some data regarding causes of death, "old age" was previously reported as a common reason for the euthanasia of adult horses.
The research was carried out by Joanne Ireland at the University of Liverpool and led by Dr Gina Pinchbeck. Ireland surveyed horse owners living in the North-West and Midlands areas of England and North Wales who have a horse aged 15 years or older. 918 owners of geriatric horses were followed in a cohort study and 118 mortalities were reported during the 18 month follow-up period, of which 111 were euthanased.
The researchers found that 24% of horses were euthanased due to lameness; an additional 12% were euthanased due to laminitis - a common cause of lameness. After lameness, colic was the next most common cause of euthanasia, with 21% of owners citing this as the main reason.
In an earlier stage of the project, the researchers had found that half the geriatric horses surveyed suffered from lameness, but only 24% of owners reported the problem.
Dr Pinchbeck said: "Although lameness is common in older horses, this is the first study to quantify its contribution to their mortality.
"Owners are often missing the early signs of lameness in their horse, which means the condition isn't being managed and may deteriorate faster."
Dr Pinchbeck said it would be useful to carry out further research into lameness in geriatric horses to find out the main causes of lameness and how these may be prevented or treated.
The research team also found that half of the horses euthanased were suffering from concurrent health problems and these influenced the owner's decision to euthanase in 43% of cases. The most frequently reported additional health problems were musculoskeletal problems, such as arthritis.
The mortality rate among the horses surveyed was 11 per 100 horse-years at risk, meaning that if 100 geriatric horses were followed for a year, an average of 11 would die. The mortality rate for horses over 30 years of age was over five times the rate than in horses aged 15 - 19 years.
Jeanette Allen, Chief Executive of The Horse Trust, said the data provided by this research is likely to provide useful information for both horse owners and vets to enable them to improve the welfare of older horses. She said: "As there are a significant number of geriatric horses in the UK, it is vital that we understand more about the health problems that affect them. We hope that more owners of older horses will give their horse an annual health-check to enable the horse to have a longer, healthier life."
The research was published in the September 2011 issue of Preventive Veterinary Medicine.
Vetoquinol has announced the launch of Equistro Flexadin UCII, an equine joint supplement.
Equistro Flexadin UCII contains a new ingredient, UC-II, which the company claims is one of the most effective and influential ingredients available that aids and supports healthy joint function.
To celebrate the launch of Flexadin UCII Vetoquinol is offering a £10 money off voucher available through purchases of Horse & Hound magazine starting from November 10th.
Caitríona Mullin, Equine Product Manager at Vetoquinol UK Ltd said: "We are very excited about the launch of Flexadin UCII in the UK and Ireland, we have already received excellent feedback from our German and French colleagues. Flexadin UCII is a product that will further enhance our premium range of equine supplements formulated specifically for the performance horse."
Pet owners who believe in preventative healthcare have maintained or increased the money they spend on their pets this year, and 84% visited their vet at least once in 2010, up from 78% in 2007, according to a survey commissioned by the National Office of Animal Health.
According to the survey of 1000 owners carried out by Noesis, 44% of 'preventers' increased their spending on their pets in the last year with only a very small number (5%) decreasing it. There has also been a significant increase in the number of dogs insured by this group since 2007, which now stands at 55% compared to 41% in 2007.
The research covered both 'preventer' and 'non-preventer pet owners and sought to understand: awareness of preventative medicine in cats and dogs; how the decision is made as to what areas of preventative medicine are important and which to adopt; what types of preventative medicine are carried out and the reasons and frequency of this behaviour as well as the sources of information.
In addition to visiting their vet more frequently and spending more on their pets, preventers also visited a pet shop significantly more often than non-preventers with nearly two thirds (61%) of preventers visiting at least once a month compared to 36% of non-preventers, a figure that has decreased from 43% in 2007.
Looking at specific preventative treatments, attitudes to vaccination had not changed between the 2007 and 2010 surveys, with preventers believing that being a responsible pet owner means regularly vaccinating your pet, while non-preventers did not believe vaccination was relevant to their situation. This points to a clear need to educate non-preventers to break habits that have sometimes been handed down from generation to generation.
Most owners from both groups had used a flea treatment on their pets in the past two years although 68% of preventers were much more proactive in their usage of flea products compared to only 40% of non-preventers. Cats (80%) are more likely to have been treated than dogs (69%) among both groups of owners although flea treatment of cats has significantly decreased among non-preventers since 2007.
Use of wormers was also in decline. Although 86% of preventers worm proactively as part of a healthcare routine for their pet, this figure has decreased from 96% in 2007. Non preventers chose not to worm because they did not see the need, citing reasons such as their pet being fit and well or not going outdoors. Likewise, although preventers are more likely than non-preventers to be aware of the zoonotic implications of pet parasites, this awareness had decreased since 2007 pointing to the need for more work to be done on this aspect of pet health. On a more upbeat note, those that were worming proactively wormed their pets more frequently with 50% worming at least every three months in 2010 which was significantly more than compared to 41% in 2007.
When asked where they obtained general healthcare advice, the vet was the most frequently cited source of information with 84% of preventers and 58% of non-preventers referencing their vet. The internet is an increasingly important information channel for non-preventers with almost a third (31%) citing it as their source for pet healthcare advice, an increase from 25% in 2007.
There was huge interest from both groups (87% of preventers and 79% of non-preventers) in using a dedicated website such as NOAH's http://www.pethealthinfo.org.uk/ which 10% of the pet owners surveyed had heard of. It was welcomed for providing easy access, immediate, independent advice and being written by veterinary experts.
Commenting on the research, Phil Sketchley, chief executive of NOAH said: "We commissioned the original piece of research in 2007 to understand the differences between both groups of pet owners and understand where they sourced their information in order to influence the pet healthcare habits of the non-preventers in particular. The importance of the internet as a source of information proved that our strategy to launch http://www.pethealthinfo.org.uk/ was on target and the latest survey shows that this channel is increasingly important, particularly among non-preventers.
"The 2011 survey also reveals some positive insights into the preventative healthcare habits of those pet owners that we termed preventers. This group are more likely to insure their pet (45% vs 12%), go to the vet at least once a year (84% vs 30%) and visit a pet shop at least on a monthly basis (61% vs 36%). And, as a final piece of good news, this group have increased their total spend on their pets in the last year and very few members of either group had decreased their spend.
"Whilst all pet owners consider themselves responsible clearly some do not see regular preventative healthcare as part of that responsibility. So there remains a clear need to educate pet owners, particularly the non-preventers, to change some of the patterns of behaviour and complacency regarding their pet's health that have become entrenched and seem to have been influenced by friends and family."
The Veterinary Marketing Association is running a free seminar on Thursday 24th November from 5-7pm for any delegates of the London Vet Show, or those in the vicinity, that feel they'd like to learn about the principles of marketing.
The VMA says that in today's competitive environment, the key to success for a veterinary business is often making oneself heard and standing out above the competition, but questions how many vets are taught any marketing at college or whether marketing is something that most vets just pick up over time?
The VMA's Principles of Marketing seminar will aim to address the basics in marketing, with an emphasis on the veterinary sector. It's taking place at the Hilton Hotel, London Olympia, a few minutes walk from the show.
The VMA has enlisted the services of Paul Fifield (Visiting Professor in Marketing Strategy at the Southampton University School of Management) to deliver the seminar.
This event is open to anyone and entry is free. As spaces are limited to a maximum of 60, registration is strongly advisable. For more information, or to register, please visit the VMA's website - http://www.vma.org.uk/.
The seminar will be followed by a free buffet and time for questions.
Boehringer Ingelheim Vetmedica and the Feline Advisory Bureau (FAB) have launched Spot The Signs, a campaign designed to help owners spot the signs of painful, age-related conditions in cats, such as arthritis.
According to the company, which makes Metacam, 46% of cats are now classed as 'mature and older', and 87% of vets have treated cats aged 22 or more. Yet a survey of 3000 cat owners found that 75% would not recognise the signs of chronic pain in their cat. And despite 50% of owners believing that cats suffer pain the same way as humans, 78% of cats had never been taken to the vet for an old age check up.
99% of 77 veterinary surgeons surveyed agreed that chronic pain often goes unnoticed and that signs of pain can be confused with cats simply getting old. When shown a list of common signs of long term pain in cats, 65% of owners recognised at least one of these signs in their own cat.
Claire Bessant, leading feline author and CEO of FAB, said: "In a recent study, 65% of cats aged 12 and above showed evidence of arthritis when X-rayed. The survey also showed that a large proportion of cats do show signs that may be caused by chronic pain, including becoming withdrawn, reduced grooming and reduced activity, but these were not attributed to pain by the owners. Arthritis has only just been recognised by the veterinary profession as a major problem in cats and so it is not surprising that 80% of cat owners do not realise that their cats can develop this painful condition."
Most owners understand that arthritis can cause significant pain and discomfort, and 93% said they would feel guilty if their cat was in pain and they hadn't realised. 65% of Brits see their cat as member of the family, with 20% saying their cat is like a child to them.
The Spot the Signs campaign is being 'fronted' by Jess the Cat, Postman Pat's sidekick, with expert support from a panel of cat medicine and behaviour specialists including leading feline author Claire Bessant and VetSurgeon.org / VetNurse.co.uk blogger, Pete Wedderburn MRCVS. The campaign includes support materials for veterinary practices and a facebook page.
Claire Fowler, Boehringer Ingelheim, said: "Despite a steady increase in the number of cases of arthritis and chronic pain in cats being diagnosed, our research shows awareness amongst cat owners of how to look for pain in their cats remains surprisingly low, despite 86% saying they would want their vet to let them know if their cat might be in pain. For many owners, spotting the signs of pain in their cat can be difficult, so we have set out to educate cat owners about what to look for and to encourage them to consult their vet or vet nurse if they are concerned."
Following the announcement from the Dogs Trust that the number of stray and abandoned dogs has reached an 11 year high, Pedigree has launched it's fourth annual Adoption Drive.
The campaign, which seeks to raise awareness and funds for the thousands of strayed and abandoned dogs in the UK, comes at a time when recent statistics put the number of dogs being picked up by local authorities in the last year at 126,176 - the worst in over a decade.
Since its launch, The Pedigree Adoption Drive has raised over £1million for rescue centres up and down the country who are working tirelessly to find new and loving homes for abandoned dogs. Last year alone, grants of almost a quarter of a million pounds were distributed to 34 rescue homes and went towards funding the vital refurbishment of dilapidated kennel blocks, desperately needed veterinary facilities and the supply of essential surgical equipment.
TV presenter and wildlife vet Steve Leonard, who is supporting this year's campaign, said: "Rescue centres across the country are at capacity due to the overwhelming number of stray and abandoned dogs in Britain - a number which is sadly still on the rise. We need to work together to make people aware of this issue and educate them about both the benefits and commitment involved in owning a dog. The funds and support generated by this campaign, help to give abandoned dogs everywhere a second chance at the loving homes they deserve."
During the campaign, Pedigree is sponsoring Pete Wedderburn's blog on www.vetsurgeon.org
Fiona Knight, a Customer Care Manager from the Woodcroft Veterinary Group in Cheshire, has won the 'Petplan Insurance Advisor Award 2011'.
The award, announced at the British Veterinary Nursing Congress in Kettering, recognises the hard work and dedication that Petplan Insurance Advisors do to highlight the importance of insurance to pet owners.
Fiona said: "It was such a shock to actually win the award, I'm very pleased!. All the finalists, including me, have worked incredibly hard to carry on promoting something we feel so strongly about. It's not something we can do on our own which is why I am so grateful for the dedication and support from my team at the practice.
"The Petplan PIA is such a great scheme as it helps increase the awareness of pet insurance, and really helps owners have financial security and their pets get the best treatment should anything happen."
The finalists were judged by Petplan Business Developers Lisa Allen and Spencer Jones.
Spencer said: "All three finalists have worked extremely hard to educate pet owners about pet insurance so that they are able to give their customers informed and up-to-date advice, however Fiona's commitment and dedication really stood out and she is a very deserving winner."
As part of her award Fiona receives a 16GB Ipad2 with WiFi, worth £399. The other finalists were Harriet Goulden, veterinary nurse at the Feldon Veterinary Centre in Leicestershire, and Alison Sawyer, receptionist at Medivet in Watford.
For information on how to become a PIA contact Vetline on 0800 316 8800 or alternatively log onto www.petplanpia.co.uk.
Animalcare Ltd has launched Tilmodil (tilmicosin 300mg/ml solution for injection), a semi-synthetic macrolide antibiotic licensed for pneumonia in cattle and sheep, foul in the foot in cattle, and footrot and mastitis in sheep.
According to the company, Tilmicosin is fast-acting1, long-acting2 and highly effective against the major Gram-ve bovine respiratory pathogens.2,3 In addition, the company says tissue penetration is excellent.1 In calves a single SC injection at 10mg/kg bw results in lung concentrations exceeding the MIC90 of Mannheimia haemolytica for 72 hours.2
Animalcare says that pooled data from greater than 6000 cattle has confirmed the effectiveness of tilmicosin in the treatment of bovine respiratory disease (BRD) in well-controlled, randomised field studies. Tilmodil treatment has been proven equally effective compared to antibiotics, such as florfenicol, marbofloxacin and danofloxacin.
A recent report by the Farm Animal Welfare Council estimates that three million of the national sheep flock are lame at any one time. It is estimated that footrot is responsible for greater than 90% of lameness and is present in 97% of flocks. Tilmicosin has good activity against the key Gram-ve pathogens2 and has been successfully used in the treatment of footrot.4
Tilmodil has been developed for animal use only and is administered by veterinary surgeons only. Dosage is 1ml per 30kg bw for respiratory disease and mastitis in sheep and 0.5ml per 30kg bw for interdigital necrobacillosis (foul in the foot/footrot/bovine pododermatitis).
Tilmodil is administered as a single, low volume subcutaneous (SC) injection dose and presented in 50ml multi-dose vials.
References
1. Apley M., Antimicrobial therapy of Bovine Respiratory Disease.Veterinary Clinics of North America.Food Animal Practice (1997) 13,3:159-5622. Tilmodil SPC3. Giguere S et al .,Antimicrobial therapy in Veterinary Medicine.4th edition 2006.Chp.12,2014. Winter A., Lameness in sheep. 2. Treatment and control. In Practice (2004),3, 130-139.
Woodley Equipment Company Ltd has been appointed as the UK and European master veterinary distributor for the Mythic 18 Vet haematology analyser manufactured by Orphee-Medical, Switzerland.
The Mythic 18 Vet is a fully automated, 18 parameter haematology analyser dedicated for veterinary applications. Woodley says it delivers the ultimate technology in haematology, requires little maintenance and benefits from low reagent consumption. It's quick and easy to use with touch screen technology and can produce accurate results in just 60 seconds for over 10 different species using a small sample volume.
For more information, visit: www.woodleyequipment.com, email: sales@woodleyequipment.com or call: +44(0)1204 669033
Inocul8 and the Global Alliance for Livestock Veterinary Medicines (GALVmed), have launched vetvac.org a free new online database of information about livestock and poultry vaccines.
Currently the Vetvac database contains information on nearly 2,000 livestock vaccine products produced by more than 95 manufacturers. This included cattle, sheep, goat, pig and poultry vaccines available in the UK, Australia, Africa, India, South America and the United States. It is being expanded and updated on a continuous basis, and aims to cover all markets, providing the most complete compendium of licensed livestock vaccine products available worldwide.
The database developers say that they hope Vetvac.org will be especially useful to vaccine manufacturers and developers, and animal health professionals and livestock keepers.
Josef Geoola, Vetvac's co-founder, said: "Although there are a number of on-line databases and websites that focus on livestock vaccines, none provide the global coverage that Vetvac.org aims to achieve - our product will be unique."
MSD Animal Health has launched Expertis Udder Health, a farm management tool for veterinary surgeons to better enable them to monitor and improve udder health in dairy cattle.
Expertis was presented to vets at the International Conference on Udder Health and Communication which took place in Utrecht this week.
Expertis Udder Health consists of a software programme together with educational and communication tools to help veterinary surgeons and farmers find the causes of mastitis more easily.
The Expertis Udder Health program consists of four steps: 1. A farm intake questionnaire about setting goals puts the farmer in a central position, and allows for careful listening in order to align with his/her objectives. 2. The data is analyzed, leading to the identification of the right focus points that are needed to identify areas for improvement. 3. These focus points are presented as fact sheets, i.e. a check list of risk factors for mastitis within the focus point. 4. The information is synthesized into an automatic summary of the actual situation, the udder health objectives and an open space to fill in the tailor-made advice to the farmer for improvement of the udder health status on his farm.
Jantijn Swinkels, DVM, Global Technical Director Pharmaceuticals within the Ruminants Business Unit at Merck Animal Health said: "The structured approach offered by Expertis Udder Health takes into account that mastitis is a multifactorial disease and covers all aspects that influence udder health. To save time, the analysis ensures that the focus is on the most important issues, which can differ greatly from farm to farm. The existing services provided within this tool can be used to optimize udder health on the farm".
Rinse Jan Boersma, MSc, Global Director Dairy Cattle at Merck Animal Health added: "We have developed Expertis to support veterinarians and farmers by improving our service level as well as to contribute to good veterinary practices by implementing preventive measures and prudent use of antibiotics."
MSD says that as a consequence of the reduced milk production, discarded milk, veterinary and treatment costs and extra labor costs, mastitis is considered the most important cause of economic loss for dairy operations. Recent data from Sweden indicates an average economic loss of €278 per case of clinical mastitis and of €60 per case of sub-clinical mastitis.*
The Expertis Udder Health program is being rolled out country to country, and will be distributed to veterinary surgeons via local MSD Animal Health representatives.
Reference
* Nielsen C, Østergaard S, Emanuelson U, Andersson H, Berglund B, Strandberg. Economic consequences of mastitis and withdrawal of milk with high somatic cell count in Swedish dairy herds. Animal 2010;4:1758-70
The Veterinary Marketing Association has announced details of a new award for public relations, open to veterinary practices and companies.
The VMA says this award is to recognise the value that media and public relations can add to the marketing mix. It will be awarded to the company or veterinary practice that has delivered the most innovative PR campaign during 2011, as judged by a panel of industry professionals.
Organiser Claire Edmunds said: "The VMA Awards has become a coveted event for those involved in the animal health industry to showcase their marketing achievements. A range of categories has evolved since the awards began over 20 years ago, for marketing, creative communication and new media campaigns. However, we felt that an award for PR was required to complete the marketing mix".
Jane Manning from award sponsor Splash Marketing & Communications said: "We felt it was time to give the opportunity for those involved in PR to obtain the recognition they deserve alongside their creative colleagues.
"An effective PR campaign can be a highly influential marketing tool, so it's great news that the VMA has added this new award category. We hope that companies and agencies serving the animal health sector will embrace this new opportunity to showcase their creativity and hard work".
The award is for the most innovative PR initiative published during the year. This can be a single 'one-off' event or article, or a sustained campaign over a given period. The winner and two highly commended entries will be awarded at the VMA Awards on Friday 9th March 2012 at Shakespeare's UnderGlobe Theatre, London.
Further information on the awards and ticket application forms are available at the VMA's website - http://www.vma.org.uk/ or by calling 0844 561 6157. The deadline for entries is Friday 27th January 2012.
Royal Canin has launched a new Skin Care family of dermatological diets, designed for the nutritional support of skin function in dogs with dermatosis unrelated to food intolerance or allergy.
At the same time, Royal Canin has also launched DermAlliance, a campaign to improve skin care knowledge in general veterinary practice. The 2011/2012 DermAlliance campaign will include educational initiatives such as free CPD webinars, a training roadshow, case study collaborations and competitions to win skin disease reference materials.
Gudi Stuttard BVSc MRCVS, Royal Canin's Veterinary Support Manager, said: "The Skin Care diets (available for adult dog, adult small dog and junior small dog) offer veterinarians a proven1 option for the nutritional management of dogs with common skin problems.
She added: "The large volume of skin cases we see in general practice necessitates a certain level of expertise in small animal dermatology and we believe our new Skin Care range, coupled with the creation of our dedicated DermAlliance educational campaign, will help promote greater clarity in an often confusing clinical area."
According to Royal Canin, Skin Care diets help in the nutritional management of dogs with reactive skin; they contain a patented complex to help maintain the barrier effect of the skin and high levels of essential fatty acids to help support healthy skin reactions. They also contain a synergistic complex of antioxidants to help support natural defences, and nutrients to help maintain a healthy digestive system and contribute to good oral health.
1 In a multi-centre trial on 47 dogs, the average CADESI (canine atopic dermatitis extent and severity index) score of all dogs improved by a factor of three over three months of being fed Skin Care exclusively. Average CADESI scores increased again after dogs returned to their original diets.
Eurovet Animal Health is to offer veterinary surgeons visiting the London Vet Show a free trial of Cardisure to use in newly diagnosed patients*.
In addition, for every free trial vets sign up for at the event, Eurovet will also donate £1 to The Children's Heart Association to a maximum total donation of £500. The charity is run by families and friends of affected children and aims to improve facilities for children at heart units, maintain standards of improvement as new techniques develop, raise funds to help purchase specialised equipment and support patients and their families.
Eurovet will also be running a prize draw to win one of two Thamescope Cardiology Stethoscopes each day.
The company says bulk buy discounts will also be on offer and following on from news of the recent methadone CPD seminars, the team will also be talking about Comfortan - the first EU authorised veterinary licensed methadone. They will also be taking registrations for the final seminar in the series of three, which takes place at The Gables hotel, Falfield, near Bristol on Wednesday 30th November.
Eurovet will be on stand G70.
*The trial applies to veterinary surgeons only. The free product will be supplied to the named veterinary surgeon at the registered practice address.
The British Small Animal Veterinary Association is inviting its members to submit their views on DEFRA's recently revised and published draft Rabies Control Strategy.
The BSAVA says that while the general control options for dealing with a suspected or confirmed case of classical rabies are determined by law there are a number of issues raised in this document on which its members may wish to comment.
Details are in the Consultations area under the Advice link here at bsava.com.
Please return responses to s.everitt@bsava.com by Friday 9th December 2011 to allow time to collate the comments and produce a response.
Companion Care Vets has launched a Graduate Development Programme to develop veterinary graduates into future partners in the business.
According to the company, seven graduates have so far joined the scheme. Five are from the Royal (Dick) School of Veterinary Studies in Edinburgh, one is from The Royal Veterinary College in London and one studied at the Univesitat Autònoma de Barcelona. Each has gone through a rigorous recruitment process devised by the Companion Care Vets HR team, and will be placed in one of the groups established surgeries, where the company will give them an understanding of the entire business from clinical to personal, commercial to management.
Jane Balmain, Managing Director of Companion Care Vets said: "One of my ambitions for Companion Care Vets is to ensure we play a significant role in developing standards in the veterinary profession and I believe that supporting talented veterinary graduates is key to this.
"Our rapidly expanding business is passionate about providing the highest level of pet healthcare and client service and we are proud to be able to help veterinary professionals realise their ambitions and full potential."
Placements last three years, during which Companion Care says each of the graduates will be closely mentored and their clinical learning will follow the framework developed by the RCVS as part of their Professional Development phase. Business support will be given via secondment to Companion Care's support services departments and theory based learning. All graduates are placed in practice from day one, building on their clinical experience.
One of the graduates, Katie Denholm said: "This graduate programme is a brilliant opportunity for me to put what I have learnt at University into practice. What really excited me was the modern surgeries, opportunity to be really hands-on and the added business-advice that will help me to realise my dream of one day, and I hope in the not too distant future, becoming a partner in my own practice."
Katie has been placed at Companion Care Vet's Chelmsford surgery, where veterinary surgeon and Joint Venture Partner Simone Dent said: "This scheme is a fantastic opportunity for graduates to gain all important clinical experience alongside the commercial aspects of a veterinary career. Being a vet these days affords enormous opportunities to build a successful business that provides satisfaction, financial reward and work-life balance. Katie will be given every opportunity to blossom as an integral part of our team learning, and having fun, every step of the way."
To find out more about the Graduate Development Programme please visit www.ccvets.co.uk or email graduates@companioncare.co.uk
The Registrar and Secretary of the Royal College of Veterinary Surgeons, Jane Hern, has announced that she will be standing down at the end of the year.
After 15 years in the job, Jane says she has been pleased to oversee a number of significant reforms and new initiatives in her time leading the organisation, but has decided that it is time to move on and pursue other interests.
The College says it is now embarking on a comprehensive review of its governance, committee and management structures, during which the Officers and Council will consider how best the executive should be led in future.
Jane said: "I have greatly enjoyed my time with the College and the Trust. Working with a profession held in such high regard by the public has been a real pleasure. I wish veterinary surgeons, veterinary nurses and all my colleagues all the very best for the future."
The President, Dr Jerry Davies said: "The Royal College has been very fortunate in having the benefit of Jane's wisdom and guidance for so many years, and we wish her every success in the future."
The BSAVA's Scientific Committee has issued a policy statement on the management and treatment of firework phobias in dogs.
The statement says: "It is recognised that dogs may show signs of fear or phobia of the loud noises associated with fireworks. It is the duty of veterinary surgeons to recommend and support evidence-based therapies for this noise fear or phobia in order that they may improve the welfare of animals under their care"
The statement goes on to offer recommendations and guidance for short-term management and longer-term therapy, available here.
Norbrook is expanding its NSAID range with the launch of Loxicom Injection for cattle, pigs and horses.
Norbrook says the new product, which will be available to veterinary surgeons from mid-October, offers treatment for a range of symptoms including pneumonia, acute mastitis and calf scour in cattle, swine locomotor diseases such as lameness and MMA syndrome, acute and chronic musculo-skeletal disorders and equine colic.
Rebecca Pullon, Norbrook Product Manager said: "Loxicom is our tried and trusted NSAID range which has been available in suspension or injection for cats and dogs and which has proven exceptionally popular with veterinary practices. According to the GFK data, Norbrook is the most successful generic manufacturer of Meloxicam, by some distance.
"I am delighted that we can now extend this range to include a Loxicom Injection for Cattle, Pigs and Horses, which I am confident will prove equally as popular."
"As a bio-equivalent product, Loxicom Injection for cattle, pigs and horses is as effective as the pioneer product. There is a misperception that a bioequivalent product is somehow inferior to the pioneer product, which is untrue. In order to attain a license, a company must prove that a bio-equivalent product is at least as effective as the pioneer. With Loxicom Injection for cattle, pigs and horses, it comes with the added reassurance that it has been produced by Norbrook, a world leader in animal health and veterinary pharmaceuticals manufacture."
The first steps have begun to find Petplan and The Veterinary Business Journal's Practice Manager of the Year for 2012.
Nominations are now being sought for the most accomplished UK practice managers and recommendations are welcome from any member of the veterinary team.
Three finalists will be chosen and the winner announced at the annual Petplan Veterinary Awards in April 2012.
Robin Fearon, editor of the Veterinary Business Journal, said: "It is a distinct pleasure to launch the awards programme each year knowing that at the end of it we will be able to announce another winning practice manager.
"These awards are so important in promoting the role and highlighting the crucial part that managers play in practice strategy and success - we can't wait to see your nominations."
Judges will assess candidates' applications and choose the three finalists based on their competency in areas such as staff development, financial strategy and marketing initiative.
Last year's winner Denise Coston is practice manager at Castle Veterinary Surgeons in County Durham. She said: "Winning this award has meant a lot to me because it makes you feel valued. I would say to anyone thinking of nominating their practice manager: 'just do it'.
"The role of practice manager varies in each practice and can be hard to quantify with specific measures, but it means a lot to celebrate someone getting it right. It is an excellent way to promote the role of practice manager and it is great to get recognition alongside vets and nurses."
This award is supported by the Society of Practising Veterinary Surgeons and the Veterinary Practice Management Association.
As well as a plaque commemorating their achievements, the winner will once more receive one year's free membership to the VPMA.
Nominations for this year's award close on 10 February 2012. Application packs are available from: Jackie Morrison, The Veterinary Business Journal, Olympus House, Werrington Centre, Peterborough PE4 6NA, or e-mail jackiemorrison@vbd.uk.com.
Alternatively visit www.vetsonline.com/ to download yours direct.
Dogs Trust, the UK's largest dog welfare charity, has teamed up with leading cardiac rehabilitation experts at Harefield Hospital to help patients in their final phase of coronary recovery.
The recovery programme, Hounds Help Hearts, is, according to the charity, a UK first and encourages post coronary patients to walk dogs as part of their recovery.
The Cardiac Rehabilitation team at Harefield Hospital aims to improve the physical, social and psychological well being of people after a heart attack or similar cardiac event. Among the recommendations for an ongoing healthy lifestyle, patients are being introduced to Dogs Trust Harefield where they can help staff, canine residents and themselves by walking some of the 150 dogs in their care. The charity hopes that heart hospitals UK wide will follow suit.
Hounds Help Hearts is part of a wider initiative to promote The Dog Prescription - a research document that highlights the ways dogs can improve human health. Dogs Trust is urging GPs all over the UK to prescribe a daily dose of dog with The Dog Prescription after research highlights the health benefits of dog ownership for both children and adults.
Lynda Evans, senior nurse /modern matron at Royal Brompton & Harefield NHS Foundation Trust, said: "Walking is one of the best forms of exercise for patients recovering from a cardiac event and what better way to do it than alongside a grateful canine companion. We have been running the 'Care For Your Heart' Rehabilitation Programme for more than 20 years and as a leading specialist heart and lung hospital we are always looking for new ways to help patients to enjoy the best possible quality of life when they return home. We are delighted to be working with Dogs Trust on this initiative and partnering patients with dogs to help them reach their full potential through interaction and physical exercise."
The Dog Prescription highlights the mental and physical benefits of dog ownership and interaction and names dog ownership as an aid to the recovery of post coronary patients
Clarissa Baldwin, Dogs Trust CEO said: "We undertook this research as we were aware of the health benefits of dog ownership but wanted to fully evaluate its potential. Amongst its ten points (which are not exhaustive), the prescription details health benefits including the fact that dogs can aid the recovery of post coronary patients. We want to spread the word about the health benefits of dogs and we hope that GPs and hospitals will start to encourage patients to engage with dogs for a healthier and happier lifestyle"
You can read the full research here.
Invicta Animal Health has announced its appointment as exclusive veterinary distributor in the UK for Chloraprep, a licensed human product for cutaneous antisepsis, prior to invasive procedures.
Invicta says Chloraprep is a single use, easy to apply, sterile system, available in a variety of sizes and in clear and tinted versions to enhance the visibility of the area requiring antisepsis, for instance, prior to surgery.
The sterile solution is maintained in a glass ampoule inside a protective outer case and, to prevent contamination, the patented design ensures users don't come into contact with either the contents or the patient's skin.
Rob Watkins, Managing Director of Invicta, said: "Most surgical site infections (SSI's) are the result of contamination from a patient's own skin flora1, a fact which highlights the importance of thorough and effective preparation of the skin as a proactive way to minimise the incidence of SSI's in patients."
According to the company, research has shown that Chloraprep, which contains 2% chlorhexidine and 70% isopropyl alcohol, has demonstrated significantly better antimicrobial activity than other combinations2.
Invicta says the way in which the solution is applied to the skin is as important as the solution itself. Studies show that the most effective way to apply Chloraprep is with a back and forth scrubbing movement because this gives a lower microbial count on the skin than using other application methods3. Once applied, Chloraprep is active in 30 seconds and is effective for up to 48 hours4.
Rob said: "The majority of UK hospitals and the Blood Transfusion Service already use Chloraprep and we are pleased to make this available under the provisions of the cascade."
He added: 'The veterinary nurses I've spoken to love this product, because they're fed up of immersing their dry, cracked hands in disinfectant!'
For further information, please contact Invicta Animal Health on 01403 791313 or email the company at mail@invictavet.com.
1. Florman S, Nichols RL. Am J Infect Dis 2007; 3: 51-61.2. Hibbard JS. J Infus Nurs 2005; 28: 194-207.3. Rosenthal K. Nurs Manage 2006; April: 55-66.4. Garcia R et al. Abstracts of the IDSA 40th Annual Meeting 2002; Abs 418.